CellSource (4880) Stock Overview

CellSource Co., Ltd. engages in the regenerative medicine-related and consumer businesses. The company provides processing services to extract adipose-derived stem cells from patients' adipose tissues, and to prepare platelet-rich plasma from patients' blood; and regenerative medicine therapy, as well as manufactures processed cells. It also offers Signalift series of anti-aging products, including a serum. The company was incorporated in 2015 and is headquartered in Tokyo, Japan.

4880 Stock Information

Symbol

4880

Address

Shibuya Mitake BuildingTokyo, 150-0002Japan

Founded

Trading hours

Website

https://www.cellsource.co.jp

Country

🇯🇵 Japan

Phone Number

81 3 6455 5308

CellSource (4880) Price Chart

CellSource Overview: Key Details and Summary

Stock data	2023	Change
Price	$6.47	N/A
Market Cap	$127.90M	N/A
Shares Outstanding	19.76M	5.86%
Employees	109.00	N/A

Valuation	2023	Change
P/S Ratio	4.36	N/A

Earnings	2023	Change
Revenue	$29.35M	N/A
Earnings	$6.01M	N/A
Gross Margin	0.7061	N/A
Operating Margin	0.2708	N/A
Net income margin	0.2047	N/A